Back

CD4+ follicular helper-like T cells are key players in anti-tumor immunity

Singh, D.; Ganesan, A. P.; Panwar, B.; Eschweiler, S.; Hanley, C.; Madrigal, A.; Ramirez Suastegui, C.; Wang, A.; Clarke, J.; Wood, O.; Garrido-Martin, E. M.; Chee, S.; Seumois, G.; Belanger, S.; Alzetani, A.; Woo, E.; Friedmann, P.; Crotty, S.; Thomas, G.; Sanchez-Elsner, T.; Ay, F.; Ottensmeier, C.; Vijayanand, P.

2020-01-09 immunology
10.1101/2020.01.08.898346 bioRxiv
Show abstract

To determine the nature of CD4+ T cells that provide help for generating robust anti-tumor CD8+ cytotoxic T cell (CTL) responses, we profiled the transcriptomes of patient-matched CD4+ and CD8+ T cells present in the tumor micro-environment (TME) and analyzed them jointly using integrated weighted gene correlation network analysis. We found the follicular helper T cell (TFH) program in CD4+ T cells was strongly associated with proliferation and tissue-residency in CD8+ CTLs. Single-cell analysis demonstrated the presence of TFH-like cells and features linked to cytotoxic function and their provision of CD8+ T cell help. Tumor-infiltrating TFH-like cells expressed PD-1 and were enriched in tumors following checkpoint blockade, suggesting that they may respond to anti-PD-1 therapy. Adoptive transfer or induction of TFH cells in mouse models resulted in augmented CD8+ CTL responses and impairment of tumor growth, indicating an important role of TFH-like CD4+ T cells in anti-tumor immunity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.